Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KAT2B | Q92831 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL111935 | 0.85 | MAPT (0.52) | MAPTALDH1A1LMNAKAT2BTSHR | |
| SCHEMBL29391950 | 0.85 | MAPT (0.52) | MAPTALDH1A1LMNAKAT2BTSHR | |
| SCHEMBL30808005 | 0.83 | MAPT (0.54) | MAPTALDH1A1LMNAKAT2BTSHR | |
| SCHEMBL11056141 | 0.83 | MAPT (0.54) | MAPTALDH1A1LMNAKAT2BTSHR | |
| SCHEMBL112790 | 0.83 | MAPT (0.54) | MAPTALDH1A1LMNAKAT2BTSHR | |
| SCHEMBL11059627 | 0.82 | MAPT (0.50) | MAPTALDH1A1LMNAKAT2B | |
| SCHEMBL6151634 | 0.82 | MAPT (0.52) | MAPTALDH1A1LMNAKAT2BTSHR | |
| SCHEMBL11056017 | 0.81 | KAT2B (0.60) | MAPTALDH1A1LMNAKAT2BTDP1 | |
| Bromide SCHEMBL10714879 | 0.81 | MAPT (0.51) | MAPTALDH1A1LMNAKAT2BTSHR | |
| SCHEMBL109941 | 0.80 | MAPT (0.58) | MAPTALDH1A1LMNATSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11166896-B2 | Process for dyeing and relaxing curls of keratin fibres, using reducing agents and hair dyes, and associated kit | L'OREAL (FR) | 2021-11-09 | — | — | US | disclosed |
| EP-3558462-B1 | PROCESS FOR DYEING AND RELAXING CURLS OF KERATIN FIBRES, USING REDUCING AGENTS AND HAIR DYES, AND ASSOCIATED KIT | OREAL (FR) | 2021-01-20 | — | — | EP | disclosed |
| US-20200085714-A1 | Process for Dyeing and Relaxing Curls of Keratin Fibres, Using Reducing Agents and Hair Dyes, and Associated Kit | L'OREAL (FR) | 2020-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200085714-A1 | Process for Dyeing and Relaxing Curls of Keratin Fibres, Using Reducing Agents and Hair Dyes, and Associated Kit | KRT18, KIT, KLK5 | MAPT 752/4885ALDH1A1 1653/4885LMNA 455/4885 |
| US-11166896-B2 | Process for dyeing and relaxing curls of keratin fibres, using reducing agents and hair dyes, and associated kit | KRT18, KIT, KLK5 | MAPT 752/4885ALDH1A1 1653/4885LMNA 455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.